Minocycline topical - Pfizer/Sunstar

Drug Profile

Minocycline topical - Pfizer/Sunstar

Alternative Names: Dentomycin; LS 007; Minomycin; Periocline

Latest Information Update: 20 May 2017

Price : $50

At a glance

  • Originator Sunstar; Wyeth K.K.
  • Class Amides; Antibacterials; Dimethylamines; Neuroprotectants; Small molecules; Tetracyclines
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Periodontitis
  • No development reported Anthrax

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 16 Oct 2009 Wyeth has been acquired by Pfizer
  • 31 Dec 2003 Wyeth-Lederle Japan is now called Wyeth K.K.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top